Metraipolis › archive › dc_cfb50fde9022

Metformin-A Type 2 Diabetes Mellitus Drug-And Ovarian Cancer: Anticancer Mechanisms and Therapeutic Implications — Europe PMC PMID:41897350

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41897350
DOI
10.3390/biom16030413
License (as archived)
solo-consultazione
Archived
2026-11-04T19:56:04.598Z
SHA-256 of the archived text
13dc88371ab2ad43696d8526a7cd9b521a5a1759b9f273b733fb52afd583f69c
Stable URL of this page
https://metraipolis.com/documento/dc_cfb50fde9022

How to cite

Metformin-A Type 2 Diabetes Mellitus Drug-And Ovarian Cancer: Anticancer Mechanisms and Therapeutic Implications — Europe PMC PMID:41897350 — Europe PMC (en), https://europepmc.org/article/MED/41897350 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cfb50fde9022 (Metraipolis archive dc_cfb50fde9022, sha256 13dc88371ab2ad43696d8526a7cd9b521a5a1759b9f273b733fb52afd583f69c)
BibTeX
@misc{dccfb50fde9022,
  title = {Metformin-A Type 2 Diabetes Mellitus Drug-And Ovarian Cancer: Anticancer Mechanisms and Therapeutic Implications — Europe PMC PMID:41897350},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41897350},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cfb50fde9022; sha256 13dc88371ab2ad43696d8526a7cd9b521a5a1759b9f273b733fb52afd583f69c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41897350. Agents can read the archived copy with the MCP tool read_document.